Assembly Biosciences, Inc. (ASMB) Financials

ASMB Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 235.5 million 36.9 million
Dec. 31, 2025 257.6 million 50.8 million
Sept. 30, 2025 240.0 million 57.3 million
June 30, 2025 80.8 million 62.7 million

ASMB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -22.1 million ?
Dec. 31, 2025 14.2 million 1.5 million
Sept. 30, 2025 -15.2 million 1.7 million
June 30, 2025 -16.8 million 834000

ASMB Net Income

No data available :(

ASMB Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 226.6 million 1.9 million -
Dec. 31, 2025 248.1 million - 2.1 million
Sept. 30, 2025 232.6 million - 2.8 million
June 30, 2025 75.0 million - 2.9 million

ASMB Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 16.9 million
Dec. 31, 2025 11.2 million
Sept. 30, 2025 7.7 million
June 30, 2025 7.7 million

ASMB Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 19000 14.9 million 4.7 million -
Dec. 31, 2025 24000 17.3 million 5.4 million -
Sept. 30, 2025 42000 16.6 million 5.1 million -
June 30, 2025 - 16.1 million 4.6 million -

ASMB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 8.2 million 26000
Dec. 31, 2025 42.5 million 32000
Sept. 30, 2025 10.8 million -
June 30, 2025 9.6 million 16.1 million

ASMB Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ASMB

Price: $23.33

52 week price:
15.25
39.71

Earnings Per Share: 0.08 USD

P/E Ratio: 380.13

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 311844

Ebitda: -12.4 million

Market Capitalization: 385.4 million

Links: